|
Delayed
TEL AVIV STOCK EXCHANGE
17:24:11 15/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1,132.00 ILa | -0.35% |
|
+5.89% | +3.47% |
| Market Cap | 129M 0 42.47M 36.79M 34.79M 31.49M 59.11M 4.07B 59.55M 415M 160M 2.07B 160M 156M 6.59B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 257M 0 84.54M 73.23M 69.25M 62.69M 118M 8.11B 119M 826M 318M 4.11B 318M 311M 13.11B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.35% | ||
| 1 week | +5.89% | ||
| Current month | +6.89% | ||
| 1 month | +6.19% | ||
| 3 months | +6.29% | ||
| 6 months | -4.23% | ||
| Current year | +3.47% |
| 1 week | 1,130 |  | 1,139 |
| 1 month | 1,026 | | 1,139 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,788 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 24/08/1993 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 01/11/2018 |
| President | 80 | 28/06/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 25/06/2010 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 15/04/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.35% | +5.89% | -1.91% | -31.81% | 42.47M | |
| -1.25% | +1.17% | +27.98% | +114.11% | 105B | |
| -0.95% | -3.26% | +54.82% | +165.13% | 54.11B | |
| -1.89% | -3.00% | -13.95% | +240.79% | 21.66B | |
| -0.86% | -2.17% | -10.59% | -9.14% | 8.02B | |
| -1.02% | -4.07% | -38.64% | -36.26% | 6.84B | |
| +1.56% | -3.61% | -2.45% | +14.25% | 6.36B | |
| -0.40% | -4.27% | -20.01% | -31.21% | 6B | |
| -0.03% | -0.90% | -3.85% | +18.53% | 5.02B | |
| -9.94% | -32.63% | +206.06% | +347.61% | 3.72B | |
| Average | -1.51% | -1.55% | +19.75% | +79.20% | 21.67B | |
| Weighted average by Cap. | -1.23% | -1.22% | +27.06% | +125.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 106M 91.59M 86.61M 78.41M 147M 10.14B 148M 1.03B 398M 5.14B 397M 388M 16.4B | 301M 0 98.93M 85.69M 81.03M 73.36M 138M 9.49B 139M 967M 372M 4.81B 372M 363M 15.35B |
| Net income | 6.21M 0 2.04M 1.77M 1.67M 1.51M 2.84M 196M 2.86M 19.94M 7.67M 99.21M 7.66M 7.49M 316M | -18.07M -0 -5.94M -5.15M -4.87M -4.41M -8.27M -570M -8.33M -58.07M -22.34M -289M -22.31M -21.82M -921M |
| Net Debt | 127M 0 41.77M 36.18M 34.21M 30.97M 58.13M 4.01B 58.57M 408M 157M 2.03B 157M 153M 6.48B | 128M 0 42.07M 36.45M 34.46M 31.2M 58.56M 4.04B 59M 411M 158M 2.05B 158M 155M 6.53B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/09/26 | ILA 1,132.00 | -0.35% | 639 |
| 14/09/26 | ILA 1,136.00 | -0.18% | 47 |
| 10/09/26 | ILA 1,138.00 | +5.76% | 1,001 |
| 09/09/26 | ILA 1,076.00 | +0.65% | 394 |
| 08/09/26 | ILA 1,069.00 | -1.02% | 4,242 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
